Delivery Order SPE2DR25D2106-SPE2DR26F1FVP
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $63,005.93 by the Defense Logistics Agency (DLA) on December 1, 2025, for the supply of Betaseron 0.3 mg kits. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 2, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $45,542.34 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical valued at $14,734.37. The contract is for the delivery of 0.3 mg BETASERON medication kits, which are specialty pharmaceutical products used to treat certain medical conditions. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC)...
- This federal contract award, valued at $16,526.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Betaseron 0.3 mg kits, a specialty medication, with a completion date of December 22, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $30,974.72 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply Betaseron 0.3 mg kits. The delivery order was awarded on December 11, 2023 against an existing indefinite delivery contract held by Amerisourcebergen Drug Corp, with performance to be completed by December 12, 2023. The delivery location is Amerisourcebergen's...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,155.37, is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Betaseron 0.3 mg kits, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order has a ceiling value of $51,064.44 and an ultimate completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FVPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,309.16 by the Defense Logistics Agency on November 25, 2025, for the supply of Betaseron 0.3 mg kits. The contract utilizes firm fixed pricing and carries an ultimate completion date of November 26, 2025. This award is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order supports the Defense Logistics Agency's medical supply chain operations, which provide pharmaceutical products and medical supplies to military and veteran healthcare systems. Betaseron, an interferon beta-1b medication used to treat multiple sclerosis, represents one of many specialty pharmaceutical products AmerisourceBergen supplies through its comprehensive federal contract portfolio with the Defense Health Agency and other government healthcare entities. The underlying IDC serves as a global pharmaceutical support vehicle enabling the contractor to deliver a wide spectrum of medications, vaccines, and medical supplies across multiple therapeutic domains in support of military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 11/24/25 |